Table 1 Baseline characteristics of CASCADIA study population stratified by RSV A/B illness status (n = 3237 individuals; 1188 households)a
From: Correlates of risk of respiratory syncytial virus disease: a prospective cohort study
RSV A/B illness | Total (N = 3237) | ||
|---|---|---|---|
No (n = 2932) | Yes (n = 305) | ||
Overall household characteristics (regardless of enrollment status) | |||
Enrollment site | |||
Oregon, USA | 1507 (51.40%) | 124 (40.66%) | 1631 (50.39%) |
Washington, USA | 1425 (48.60%) | 181 (59.34%) | 1606 (49.61%) |
Household density | |||
Lives alone | 21 (0.72%) | 3 (0.99%) | 24 (0.74%) |
2–4 people | 2276 (77.81%) | 217 (71.38%) | 2493 (77.21%) |
5+ people | 628 (21.47%) | 84 (27.63%) | 712 (22.05%) |
Number of children in household | |||
No children | 82 (2.80%) | 5 (1.64%) | 87 (2.69%) |
1 child | 789 (26.91%) | 64 (20.98%) | 853 (26.35%) |
2–4 children | 2018 (68.83%) | 234 (76.72%) | 2252 (69.57%) |
5+ children | 36 (1.23%) | 1 (0.33%) | 37 (1.14%) |
Household income | |||
Below study median (<$100,000) | 987 (33.66%) | 96 (31.48%) | 1083 (33.46%) |
Study median ($100,000–$124,999) | 719 (24.52%) | 78 (25.57%) | 797 (24.62%) |
Above study median (≥$125,000) | 1127 (38.44%) | 127 (41.64%) | 1254 (38.74%) |
Prefer not to say | 92 (3.14%) | 3 (0.98%) | 95 (2.93%) |
Enrolled household member characteristics | |||
Number of fully enrolled participants in household | |||
Median [Min, Max] | 3 [1, 8] | 3 [1, 7] | 3 [1, 8] |
Children in household (yes/no) | |||
Yes | 2746 (93.66%) | 288 (94.43%) | 3034 (93.73%) |
Children < 5 years attend daycare (yes/no) | |||
Yes | 830 (28.31%) | 142 (46.56%) | 972 (30.03%) |
Individual characteristics | |||
Age group | |||
6 months–1 year | 76 (2.59%) | 24 (7.87%) | 100 (3.09%) |
2–4 years | 176 (6.00%) | 57 (18.69%) | 233 (7.20%) |
5–12 years | 827 (28.21%) | 106 (34.75%) | 933 (28.82%) |
13–17 years | 332 (11.32%) | 19 (6.23%) | 351 (10.84%) |
18–50 years | 1521 (51.88%) | 99 (32.46%) | 1620 (50.05%) |
Sex assigned at birth | |||
Female | 1720 (58.66%) | 179 (58.69%) | 1899 (58.67%) |
Gender | |||
Male | 1182 (40.31%) | 123 (40.33%) | 1305 (40.32%) |
Female | 1640 (55.93%) | 174 (57.05%) | 1814 (56.04%) |
Transgender | 42 (1.43%) | 4 (1.31%) | 46 (1.42%) |
Other | 68 (2.32%) | 4 (1.31%) | 72 (2.22%) |
Race | |||
American Indian or Alaska Native | 13 (0.44%) | 1 (0.33%) | 14 (0.43%) |
Asian | 217 (7.40%) | 21 (6.89%) | 238 (7.35%) |
Black or African American | 72 (2.46%) | 4 (1.31%) | 76 (2.35%) |
Native Hawaiian or other Pacific Islander | 4 (0.14%) | 1 (0.33%) | 5 (0.15%) |
White | 2226 (75.92%) | 220 (72.13%) | 2446 (75.56%) |
Multiracial | 298 (10.16%) | 52 (17.05%) | 350 (10.81%) |
Other | 73 (2.49%) | 5 (1.64%) | 78 (2.41%) |
Hispanic | |||
Yes | 253 (8.63%) | 26 (8.52%) | 279 (8.62%) |
Health insurance | |||
Employer-sponsored health insurance | 2440 (83.22%) | 285 (93.44%) | 2725 (84.18%) |
Individual health insurance | 114 (3.89%) | 3 (0.98%) | 117 (3.61%) |
Government insurance program | 270 (9.21%) | 13 (4.26%) | 283 (8.74%) |
None | 24 (0.82%) | 1 (0.33%) | 25 (0.77%) |
Other | 42 (1.43%) | 1 (0.33%) | 43 (1.33%) |
Any smoking (yes/no) | |||
Yes | 31 (1.06%) | 0 (0%) | 31 (0.96%) |
Missing | 975 (33.25%) | 180 (59.02%) | 1155 (35.68%) |
Overall health (self-reported) | |||
Poor/fair | 75 (2.56%) | 6 (1.97%) | 81 (2.50%) |
Good/very good | 1711 (58.36%) | 128 (41.97%) | 1839 (56.81%) |
Excellent | 1146 (39.09%) | 171 (56.07%) | 1317 (40.69%) |
Comorbidities (self-reported) | |||
Asthma | 436 (14.87%) | 32 (10.49%) | 468 (14.46%) |
Chronicobstructive pulmonary disease (including chronic bronchitis and emphysema) | 7 (0.24%) | 0 (0%) | 7 (0.22%) |
Hypertension | 140 (4.77%) | 8 (2.62%) | 148 (4.57%) |
Immunocompromised | 56 (1.91%) | 3 (0.98%) | 59 (1.82%) |
Otherb | 954 (32.54%) | 57 (18.69%) | 1011 (31.23%) |
